Bas van der Baan
2023
In 2023, Bas van der Baan earned a total compensation of $66.6K as Director at LIXTE BIOTECHNOLOGY HOLDINGS, a 61% decrease compared to previous year.
Compensation breakdown
| Option Awards | $48,131 |
|---|---|
| Other | $18,478 |
| Total | $66,609 |
der Baan received $48.1K in option awards, accounting for 72% of the total pay in 2023.
der Baan also received $18.5K in other compensation.
Rankings
In 2023, Bas van der Baan's compensation ranked 2,916th out of 2,983 executives tracked by ExecPay. In other words, der Baan earned more than 2.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,916 out of 2,983 | 2nd |
Division Manufacturing | 1,615 out of 1,637 | 1st |
Major group Chemicals And Allied Products | 894 out of 906 | 1st |
Industry group Drugs | 858 out of 869 | 1st |
Industry Pharmaceutical Preparations | 618 out of 627 | 1st |
Source: SEC filing on November 4, 2024.
der Baan's colleagues
We found four more compensation records of executives who worked with Bas van der Baan at LIXTE BIOTECHNOLOGY HOLDINGS in 2023.